1h Free Analyst Time
The publisher has been monitoring the vascular grafts market and it is poised to grow by $1.55 bn during 2022-2026, accelerating at a CAGR of 7.22% during the forecast period. The report on the vascular grafts market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the ubiquity of CVDs and other vascular disorders, a growing shift toward MI techniques, and a high frequency of endovascular aortic repair (EVAR).
The vascular grafts market analysis includes product segment and geographic landscape.
The vascular grafts market is segmented as below:
By Product
- Endovascular grafts
Bypass grafts - Hemodialysis grafts
- Peripheral grafts
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the technological improvements as one of the prime reasons driving the vascular grafts market growth during the next few years. Also, product approvals coupled with R and D activities and emergence of next-generation TEVGs will lead to sizable demand in the market.
The report on vascular grafts market covers the following areas:
- Vascular grafts market sizing
- Vascular grafts market forecast
- Vascular grafts market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vascular grafts market vendors that include Abbott Laboratories, Artivion Inc., Aruga Technologies, B. Braun Melsungen AG, Becton Dickinson and Co., Bentley InnoMed GmbH, BIOTRONIK SE and Co. KG, BIOVIC Sdn Bhd, Cardinal Health Inc., Cook Group Inc., Endologix Inc., Getinge AB, Heart Medical Europe BV, InnAVasc Medical Inc., Japan Lifeline Co. Ltd., LeMaitre Vascular Inc., Lombard Medical Ltd., Medtronic Plc, MicroPort Scientific Corp., Terumo Corp., Vascular Graft Solutions Ltd., and W. L. Gore and Associates Inc.. Also, the vascular grafts market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global vascular grafts market: Abbott Laboratories, Artivion Inc., Aruga Technologies, B. Braun Melsungen AG, Becton Dickinson and Co., Bentley InnoMed GmbH, BIOTRONIK SE and Co. KG, BIOVIC Sdn Bhd, Cardinal Health Inc., Cook Group Inc., Endologix Inc., Getinge AB, Heart Medical Europe BV, InnAVasc Medical Inc., Japan Lifeline Co. Ltd., LeMaitre Vascular Inc., Lombard Medical Ltd., Medtronic Plc, MicroPort Scientific Corp., Terumo Corp., Vascular Graft Solutions Ltd., and W. L. Gore and Associates Inc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological improvements."
According to the report, one of the major drivers for this market is the ubiquity of CVDS and other vascular disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Artivion Inc.
- Aruga Technologies
- B. Braun Melsungen AG
- Becton Dickinson and Co.
- Bentley InnoMed GmbH
- BIOTRONIK SE and Co. KG
- BIOVIC Sdn Bhd
- Cardinal Health Inc.
- Cook Group Inc.
- Endologix Inc.
- Getinge AB
- Heart Medical Europe BV
- InnAVasc Medical Inc.
- Japan Lifeline Co. Ltd.
- LeMaitre Vascular Inc.
- Lombard Medical Ltd.
- Medtronic Plc
- MicroPort Scientific Corp.
- Terumo Corp.
- Vascular Graft Solutions Ltd.
- W. L. Gore and Associates Inc.